Corcept Therapeutics Incorporated shares owned by Thrivent Financial for Lutherans
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Thrivent Financial for Lutherans
from 13F filings
Historical chart of Thrivent Financial for Lutherans investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Thrivent Financial for Lutherans consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Thrivent Financial for Lutherans
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $2.5M | 63k | 40.31 |
| 2025-12-31 | $2.2M | 64k | 34.81 |
| 2025-09-30 | $5.6M | 68k | 83.11 |
| 2025-06-30 | $5.1M | 69k | 73.40 |
| 2025-03-31 | $7.8M | 69k | 114.21 |
| 2024-12-31 | $3.6M | 72k | 50.39 |
| 2024-09-30 | $3.4M | 73k | 46.28 |
| 2024-03-31 | $2.0M | 79k | 25.19 |
| 2023-09-30 | $2.2M | 83k | 27.24 |
| 2023-06-30 | $1.9M | 87k | 22.25 |
| 2023-03-31 | $2.1M | 95k | 21.66 |
| 2022-12-31 | $2.0M | 98k | 20.31 |
| 2022-09-30 | $2.5M | 99k | 25.64 |
| 2022-06-30 | $2.2M | 94k | 23.78 |
| 2022-03-31 | $1.7M | 78k | 22.52 |
| 2021-12-31 | $1.5M | 77k | 19.80 |
| 2021-09-30 | $1.7M | 84k | 19.68 |
| 2021-06-30 | $1.9M | 86k | 22.00 |
| 2021-03-31 | $2.1M | 87k | 23.79 |
| 2020-12-31 | $2.3M | 87k | 26.16 |
| 2020-09-30 | $1.5M | 86k | 17.41 |
| 2020-06-30 | $1.5M | 86k | 16.82 |
| 2020-03-31 | $1.0M | 86k | 11.89 |
| 2019-12-31 | $991k | 82k | 12.10 |
| 2019-09-30 | $1.1M | 81k | 14.13 |
| 2019-06-30 | $913k | 82k | 11.15 |
| 2019-03-31 | $943k | 80k | 11.75 |
| 2018-12-31 | $984k | 74k | 13.36 |
| 2018-09-30 | $1.0M | 72k | 14.02 |
| 2018-06-30 | $1.0M | 66k | 15.71 |
| 2018-03-31 | $1.1M | 64k | 16.46 |
| 2017-12-31 | $1.0M | 57k | 18.07 |
More positions owned by Thrivent Financial for Lutherans
View all positions for Thrivent Financial for Lutherans
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated